Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

241
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
241
Esophagus01:24

Esophagus

1.2K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
1.2K
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

155
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
155
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

144
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
144
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

264
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
264
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

276
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stage-Specific Drivers of Clinical Progression in Advanced Chronic Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Hepatic Venous Pressure Gradient, Noninvasive Tests, and Prognosis Across the Subtypes of Advanced Steatotic Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Role of relaxing lateral incisions as an add-on to the difficult hiatal repair in redo and giant hernia cases.

Surgery·2026
Same author

Sex Does Not Affect the Performance of Noninvasive Tests for Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease.

The American journal of gastroenterology·2026
Same author

Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis D.

Alimentary pharmacology & therapeutics·2026
Same author

Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness Measurement.

Liver international : official journal of the International Association for the Study of the Liver·2026

Related Experiment Video

Updated: Aug 23, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

517

[Esophageal Cancer].

Felix Böhme1, Krisztina Racz2, Christian Sebesta2

  • 12. Medizinische Abteilung, Klinik Donaustadt, Langobardenstraße 122, 1220, Wien, Österreich. felix.boehme@gesundheitsverbund.at.

Wiener Medizinische Wochenschrift (1946)
|November 1, 2022
PubMed
Summary

Esophageal cancer is a deadly disease with increasing incidence, particularly adenocarcinoma in Western countries. Early detection and tailored treatments are crucial for improving patient outcomes.

Keywords:
AdenocarcinomaDysphagiaEsophageal cancerEsophagusSquamous cell carcinoma

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.5K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

413

Related Experiment Videos

Last Updated: Aug 23, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

517
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.5K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

413

Area of Science:

  • Oncology
  • Gastroenterology

Context:

  • Esophageal cancer is the sixth most common and eighth deadliest cancer globally, with 600,000 new cases annually.
  • Incidence varies geographically, with squamous cell carcinoma prevalent in Africa/Asia and adenocarcinoma rising in North America/Europe.
  • Risk factors include alcohol, smoking, obesity, and conditions like esophageal stenosis or achalasia.

Purpose:

  • To provide an overview of esophageal cancer epidemiology, risk factors, diagnosis, and treatment strategies.
  • To highlight the challenges in early detection due to unspecific early-stage symptoms.
  • To outline current therapeutic approaches based on disease stage.

Summary:

  • Esophageal cancer presents a significant global health challenge with poor prognosis and high mortality.
  • Diagnosis relies on gastroscopy, CT, PET, and endosonography, often occurring at late stages.
  • Treatment ranges from endoscopic resection for early stages to surgery, radiochemotherapy, and palliative care for advanced disease.

Impact:

  • Emphasizes the need for improved prevention and early screening strategies for esophageal cancer.
  • Underscores the importance of understanding risk factors for targeted interventions.
  • Informs clinical practice regarding staging and multimodal treatment selection for esophageal cancer patients.